DK223177A - Fremgangsmade til fremstilling af p-acylaminobenzamid-forbindelser eller salte deraf - Google Patents

Fremgangsmade til fremstilling af p-acylaminobenzamid-forbindelser eller salte deraf

Info

Publication number
DK223177A
DK223177A DK223177A DK223177A DK223177A DK 223177 A DK223177 A DK 223177A DK 223177 A DK223177 A DK 223177A DK 223177 A DK223177 A DK 223177A DK 223177 A DK223177 A DK 223177A
Authority
DK
Denmark
Prior art keywords
acylaminobenzamide
salts
compounds
procedure
preparation
Prior art date
Application number
DK223177A
Other languages
Danish (da)
English (en)
Inventor
A J Nelson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK223177A publication Critical patent/DK223177A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
DK223177A 1976-05-26 1977-05-20 Fremgangsmade til fremstilling af p-acylaminobenzamid-forbindelser eller salte deraf DK223177A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/690,300 US4044147A (en) 1976-05-26 1976-05-26 N-(acyl)-p-amino-N'-(monosubstituted)-benzamide anti-ulcer agents

Publications (1)

Publication Number Publication Date
DK223177A true DK223177A (da) 1977-11-27

Family

ID=24771930

Family Applications (1)

Application Number Title Priority Date Filing Date
DK223177A DK223177A (da) 1976-05-26 1977-05-20 Fremgangsmade til fremstilling af p-acylaminobenzamid-forbindelser eller salte deraf

Country Status (10)

Country Link
US (1) US4044147A (nl)
JP (1) JPS52144640A (nl)
BE (1) BE855022A (nl)
DE (1) DE2723051C3 (nl)
DK (1) DK223177A (nl)
FR (1) FR2352790A1 (nl)
GB (1) GB1539862A (nl)
IE (1) IE44499B1 (nl)
LU (1) LU77403A1 (nl)
NL (1) NL170135C (nl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2600513A1 (de) * 1976-01-08 1977-07-28 Hoechst Ag Acylamino(alkyl)benzolderivate und verfahren zu ihrer herstellung
US4500714A (en) * 1981-10-15 1985-02-19 Chugai Seiyaku Kabushiki Kaisha 3-Substituted-ureido-N-pyridyl benzamides
US4735956A (en) * 1985-09-13 1988-04-05 Merck & Co., Inc. Certain 1,4-dihydro-2,6-di-lower hydrocarbyl-4-heterocyclic-3,5-pyridine dicarboxylates which are useful as calcium channel blockers
US5643965A (en) * 1995-04-03 1997-07-01 Centaur Pharmaceuticals, Inc. Aminobenzamide compounds for the treatment of neurodegenerative disorders
US5658953A (en) * 1995-04-03 1997-08-19 Centaur Pharmaceuticals, Inc. Pharmaceutical compositions of acetamidobenzamide compounds for neurodegenerative disorders
US5955506A (en) * 1996-04-03 1999-09-21 Centaur Pharmaceuticals, Inc. Benzamides for neurodegenerative disorder treatment
AU7353300A (en) 1999-09-08 2001-04-10 Guilford Pharmaceuticals Inc. Non-peptidic cyclophilin binding compounds and their use
US6656971B2 (en) 2001-01-25 2003-12-02 Guilford Pharmaceuticals Inc. Trisubstituted carbocyclic cyclophilin binding compounds and their use
EP1893570A4 (en) * 2005-06-22 2009-12-23 Reddy Manne Satynarayana IMPROVED PROCESS FOR THE PREPARATION OF EZETIMIBE
US20070049748A1 (en) * 2005-08-26 2007-03-01 Uppala Venkata Bhaskara R Preparation of ezetimibe

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2212268C3 (de) * 1971-03-15 1979-09-13 Sumitomo Chemical Co., Ltd., Osaka (Japan) N-Halogenacetylanilinoessigsäureester, Verfahren zu deren Herstellung und diese enthaltende herbicide Massen
JPS50157336A (nl) * 1974-06-11 1975-12-19

Also Published As

Publication number Publication date
IE44499B1 (en) 1981-12-16
NL170135C (nl) 1982-10-01
LU77403A1 (nl) 1979-01-19
IE44499L (en) 1977-11-26
FR2352790A1 (fr) 1977-12-23
US4044147A (en) 1977-08-23
DE2723051A1 (de) 1977-12-01
JPS52144640A (en) 1977-12-02
FR2352790B1 (nl) 1980-11-14
BE855022A (fr) 1977-11-25
DE2723051C3 (de) 1980-07-31
NL170135B (nl) 1982-05-03
GB1539862A (en) 1979-02-07
NL7705565A (nl) 1977-11-29
DE2723051B2 (de) 1979-11-22
JPS574626B2 (nl) 1982-01-27

Similar Documents

Publication Publication Date Title
DK56077A (da) Fremgangsmade til fremstilling af 3-quinolincarboxylsyrederivater eller additionssalte deraf
DK499778A (da) Fremgangsmaade til fremstilling af 9-(omegaheteroarylamino-alkylamino)-erythromyciner eller salte deraf
DK358980A (da) Fremgangsmaade til fremstilling af salte af (+)-katekin
DK154289C (da) Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller salte deraf
DK503080A (da) Fremgangsmaade til fremstilling af imdazolderivater eller salte deraf
DK273479A (da) Fremgangsmaade til fremstilling af 5-phenylpyrazol-forbindelser eller salte deraf
DK5976A (da) Fremgangsmade til fremstilling af biphenyloxyderivater eller salte heraf
DK392877A (da) Fremgangsmaade til fremstilling af phenylethylaminer eller syreadditionssalte heraf
DK76578A (da) Fremgangsmaade til fremstilling af d,1-5-methyltetrahydrofolinsyre eller salte deraf
DK27078A (da) Fremgangsmaade til fremstilling af imidazoquinoliner eller salte deraf
DK276177A (da) Fremgangsmade til fremstilling af gammapyron-forbindelser
DK324979A (da) Fremgangsmaade til fremstilling af imidazoquinoxaliner eller salte deraf
DK385777A (da) Fremgangsmaade til fremstilling af cephalosporinderivater eller salte deraf
DK511878A (da) Fremgangsmaade til fremstilling af imidazobenzoazepiner eller salte deraf
DK75878A (da) Fremgangsmaade til fremstilling af 20,21,-di-noreburnameninderivater eller additionssalte deraf
DK223177A (da) Fremgangsmade til fremstilling af p-acylaminobenzamid-forbindelser eller salte deraf
DK232777A (da) Fremgangsmade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
DK20077A (da) Fremgangsmade til fremstilling af salte af 3,3-dimethyl-2-oxo-smorsyre
DK152042C (da) Analogifremgangsmaader til fremstilling af n-cycloalkylmethyl-2-phenyl-aminoimidazolin-forbindelser eller syreadditionssalte deraf
DK58677A (da) Fremgangsmade til fremstilling af m-trifluormethylphenylpiperidinderivater eller additionssalte deraf
DK147623C (da) Analogifremgangsmaade til fremstilling af azapurinderivater eller salte deraf
DK154970C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater
DK338376A (da) Fremgangsmade til fremstilling af aminobenzocycloheptenderivater eller additionssalte deraf
DK127676A (da) Fremgangsmade til fremstilling af 9-alkylamino-erythromyciner eller salte deraf
DK115379A (da) Fremgangsmaade til fremstilling af dilignoler eller dilignollignende forbindelser eller salte heraf